Page 103 - 《南京医科大学学报（自然科学版）》2026年第3期

第46卷第3期 葛 愿，蔡岩坡，李明辉，等. 术前左心室射血分数作为迷宫Ⅳ射频消融联合瓣膜术后房颤复发独立
2026年3月 预测因子的倾向性评分匹配研究［J］. 南京医科大学学报（自然科学版），2026，46（3）：403-412 ·411 ·

［9］ BADHWAR V，RANKIN J S，DAMIANO R J，et al. The 学版），2023，48（7）：995-1007
society of thoracic surgeons 2017 clinical practice guide⁃ JIANG Z N，SONG L，LIANG C S，et al. Prediction model
lines for the surgical treatment of atrial fibrillation［J］. of atrial fibrillation recurrence after Cox ⁃ Maze Ⅳ proce⁃
Ann Thorac Surg，2017，103（1）：329-341 dure in patients with chronic valvular disease and atrial
［10］ISHII Y，SAKAMOTO S I，MIYAGI Y，et al. Risk factors fibrillation based on machine learning algorithm［J］. Jour⁃
of recurrence of atrial fibrillation（AF）after AF surgery in nal of Central South University. Medical Science，2023，
patients with AF and mitral valve disease［J］. Semin Thorac 48（7）：995-1007
Cardiovasc Surg，2018，30（3）：271-278 ［21］JOGLAR J A，CHUNG M K，ARMBRUSTER A L，et al.
［11］LI T Z，LU N M，DONG Y X.Risk factors for recurrence of 2023 ACC/AHA/ACCP/HRS guideline for the diagnosis
atrial fibrillation within 3 years after radiofrequency abla⁃ and management of atrial fibrillation：a report of the
tion［J］. Heart Surg Forum，2024，27（11）：E1312-E1318 American college of cardiology/American heart associa⁃
［12］ZHANG P，LIU W H，ZHAO Q，et al. Risk factors for late tion joint committee on clinical practice guidelines［J］.
recurrence in patients with nonvalvular atrial fibrillation Circulation，2024，149（1）：e1-e156
after radiofrequency catheter ablation［J］. Ann Noninva⁃ ［22］ ROSA G L，MORILLO C A，QUINTANILLA J G，et al.
sive Electrocardiol，2022，27（2）：e12924 Practical approach for atrial cardiomyopathy characteriza⁃
［13］ NATTEL S，HARADA M. Atrial remodeling and atrial tion in patients with atrial fibrillation［J］. Rev Esp Cardiol
fibrillation：recent advances and translational perspec⁃ （Engl Ed），2024，77（8）：656-666
tives［J］. J Am Coll Cardiol，2014，63（22）：2335-2345 ［23］ LIU M N，LONG X R，XU J，et al. Hypertensive heart
［14］NGUYEN P M. Divergence between left ventricular ejec⁃ disease and myocardial fibrosis：How traditional Chinese
tion fraction and global longitudinal strain by cardiac medicine can help addressing unmet therapeutical
magnetic resonance as a new predictor of myocardial needs［J］. Pharmacol Res，2022，185：106515
fibrosis burden in hypertrophic cardiomyopathy［J］. Car⁃ ［24］SANDEEP B，DING W H，HUANG X，et al. Mechanism
diovasc Res，2024，120（Supplement_1）：cvae088.113 and prevention of atrial remodeling and their related
［15］卢甜甜，张 轶. 射血分数保留性心力衰竭左心室心肌 genes in cardiovascular disorders［J］. Curr Probl Cardiol，
力学变化及评估的研究进展［J］. 心血管病学进展， 2023，48（1）：101414
2022，43（4）：331-334 ［25］ ILYAS M H，SHARIH A M，TUKUR JIDO J，et al. Screen⁃
LU T T，ZHANG Y. Research progress on left ventricular ing for atrial fibrillation：risks，benefits，and implications
myocardial mechanics changes and evaluation in heart on future clinical practice［J］. Curr Treat Options Cardio⁃
failure with preserved ejection fraction［J］. Advances in vasc Med，2024，26（8）：233-242
Cardiovascular Diseases，2022，43（4）：331-334 ［26］GAL P，MARROUCHE N F. Magnetic resonance imaging
［16］LIU Y K，QIN J. Tuning⁃parameter⁃free propensity score of atrial fibrosis：redefining atrial fibrillation to a syn⁃
matching approach for causal inference under shape drome［J］. Eur Heart J，2017，38（1）：14-19
restriction［J］. J Econom，2024，244（1）：105829 ［27］OKADA M，TANAKA N，TANAKA K，et al. Association
［17］SZALAY Z A，SKWARA W，PITSCHNER H F，et al. The between myocardial wall thickness and left ventricular
maze operation⁃surgical therapy of chronic atrial fibrilla⁃ functional recovery after catheter ablation of atrial fibrilla⁃
tion：modification to mini⁃maze operation［J］. Z Kardiol， tion in patients with reduced ejection fraction［J］. Eur
2000，89（Suppl 10）：29-34 Heart J，2021，42（Supplement_1）：ehab724.0508
［18］MCGILVRAY M M O，BAKIR N H，KELLY M O，et al. ［28］ALBAR Z，ALBAKRI M，HAJJARI J，et al. Inflammatory
Efficacy of the stand⁃alone Cox⁃Maze Ⅳ procedure in markers and risk of heart failure with reduced to preserved
patients with longstanding persistent atrial fibrillation［J］. ejection fraction［J］. Am J Cardiol，2022，167：68-75
J Cardiovasc Electrophysiol，2021，32（10）：2884-2894 ［29］DERVIS E，YAKUT I，INAN D. The prognostic signifi⁃
［19］ ARDELEANU I，FLORIA M，BADULESCU O V，et al. cance of the pan⁃immune⁃inflammation value in patients
Clinical and biological profile of patients with non⁃valvu⁃ with heart failure with reduced ejection fraction［J］. Diag⁃
lar atrial fibrillation and hemodynamic significant valvu⁃ nostics（Basel），2025，15（13）：1617
lar heart disease［J］. Rev Chim，2019，70（9）：3412-3415 ［30］ISHIBASHI Y，KASAMA S，ISHII H. Cardiac sympathetic
［20］蒋泽楠，宋 珑，梁春水，等. 基于机器学习的慢性 activity in patients suffering from heart failure with
瓣膜病合并心房颤动患者行 Cox 迷宫Ⅳ手术后心 improved ejection fraction［J］. J Nucl Cardiol，2025，48：
房颤动复发风险预测模型［J］. 中南大学学报（医 102196